A
Apotea
An online drugs store with free shipping
About Apotea
Apotea is a Swedish online pharmacy that has established a strong market position through its e-commerce business model. The company offers a wide range of prescription and non-prescription products, delivered directly to consumers with a promise of speed and competitive pricing. By operating exclusively online, Apotea has a cost-effective structure that allows it to maintain its price-competitive advantage.
The company's target market is broad, encompassing anyone in Sweden in need of pharmacy products. Its business model is based on high sales volumes and efficient logistics, supported by a highly automated warehouse. This focus on operational efficiency enables Apotea to handle a large number of orders and maintain its delivery promises. The company generates revenue by selling pharmaceutical and healthcare-related products directly to consumers.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2011
- Headquarters
- Stockholm, Sweden
- Listing
- IPO 2024
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Jonas Nordlander
Neudi & C:o
Sven Hagströmer
Alecta
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Apotea on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Apotea on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.